SHINE Psychosocial Intervention for Adolescents With a Parent Diagnosed With Cancer
(SHINE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
e purpose of this study is to develop and evaluate SHINE (Support and Healing Intervention for Navigating Parental Cancer Experiences), a family-centered program designed to support adolescents whose parent has been diagnosed with cancer.
The study has two phases. In the first phase, parents and adolescents will participate in interviews or focus groups to help researchers understand their experiences and identify the types of support that families need. Information from these discussions will be used to refine the SHINE program.
In the second phase, families will be randomly assigned to either receive the SHINE program or continue with their usual supportive care. The SHINE program consists of approximately four sessions delivered over 8 weeks and focuses on improving communication, coping skills, resilience, and emotional well-being. Adolescents will complete questionnaires before the program begins, immediately after the 8-week intervention period, and 3 months later.
Researchers will evaluate whether SHINE is feasible to deliver, acceptable to families, and shows promise for improving psychosocial outcomes among adolescents coping with a parent's cancer diagnosis.
Who Is on the Research Team?
Sarah E Messiah, MPH, PhD
Principal Investigator
University of Texas Southwestern Medical Center
Are You a Good Fit for This Trial?
This trial is for families with adolescents whose parent has been diagnosed with cancer. Both the parent and adolescent must be willing to participate in interviews, group discussions, or support sessions.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- SHINE Psychosocial Intervention
Trial Overview
The study compares a new family-centered program called SHINE—which offers about four sessions over eight weeks to help teens cope emotionally—with usual supportive care. Families are randomly assigned to either the SHINE program or standard care.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants randomized to this arm will receive the SHINE (Support and Healing Intervention for Navigating Parental Cancer Experiences) intervention in addition to usual supportive care. SHINE is a family-centered, modular psychosocial intervention consisting of approximately four sessions delivered over an 8-week period. Sessions focus on age-appropriate cancer education, family communication, coping skills, resilience, emotional support, and peer support. Intervention sessions may be delivered in person at UT Southwestern Simmons Cancer Center or remotely using HIPAA-compliant virtual platforms.
Participants randomized to this arm will receive the usual supportive care available through UT Southwestern Simmons Cancer Center. Usual supportive care may include access to oncology social work services, counseling, community resources, and other supportive services routinely available to families affected by cancer. Participants in this arm will complete the same study assessments as the intervention group but will not receive the SHINE intervention during the study period.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.